Validated High Resolution Mass Spectrometry-Based Approach for Metabolomic Fingerprinting of the Human Gut Phenotype.

Fecal samples are an obvious choice for metabolomic approaches, since they can be obtained noninvasively and allow one to study the interactions between the gut microbiota and the host. The use of ultrahigh performance liquid chromatography hyphenated to Orbitrap high-resolution mass spectrometry (UHPLC-Orbitrap HRMS) in this field is unique. Hence, this study relied on Orbitrap HRMS to develop and validate a metabolic fingerprinting workflow for human feces and in vitro digestive fluids. After chemometric sample extraction optimization, an aqueous dilution appeared necessary to comply to the dynamic range of the MS. The method was proven "fit-for-purpose" through a validation procedure that monitored endogenous metabolites in quality control samples, which displayed in both matrices an excellent linearity (R(2) > 0.990), recoveries ranging from 93% to 105%, and precision with coefficients of variation (CVs) < 15%. Finally, feces from 10 healthy individuals and 13 patients diagnosed with inflammatory bowel disease were subjected to metabolomic fingerprinting. 9553 ions were detected, as well as differentiating profiles between Crohn's disease and ulcerative colitis by means of (orthogonal) partial least-square analysis ((O)PLS)-DA (discriminate analysis) models. Additionally, samples from the dynamic gastrointestinal tract simulator (SHIME (Simulator of the Human Intestinal Microbial Ecosystem) platform) were analyzed resulting in 6446 and 5010 ions for the proximal and distal colonic samples, respectively. Supplementing SHIME feed with antibiotics resulted in a significant shift (P < 0.05) of 27.7% of the metabolites from the proximal data set and 34.3% for the distal one. As a result, the presented fingerprinting approach provided predictive modeling of the gastrointestinal metabolome in vivo and in vitro, offering a window to reveal disease related biomarkers and potential insight into the mechanisms behind pathologies.

[1]  Coral Barbas,et al.  Method validation strategies involved in non-targeted metabolomics. , 2014, Journal of chromatography. A.

[2]  G. Brufau,et al.  Metabolic effects of bile acids in the gut in health and disease. , 2014, Current medicinal chemistry.

[3]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[4]  T. Wiele,et al.  Effect of encapsulated Lactobacillus casei 01 along with pressurized-purple-rice drinks on colonizing the colon in the digestive model , 2014, Applied Microbiology and Biotechnology.

[5]  Y. Bao,et al.  The footprints of gut microbial-mammalian co-metabolism. , 2011, Journal of proteome research.

[6]  Koen Deventer,et al.  Dilute-and-shoot-liquid chromatography-mass spectrometry for urine analysis in doping control and analytical toxicology , 2014 .

[7]  E. K. Kemsley,et al.  Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. , 2011, Journal of proteome research.

[8]  Christophe Junot,et al.  Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. , 2011, Clinical biochemistry.

[9]  G. Hwang,et al.  1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model , 2010, Archives of pharmacal research.

[10]  J. Goedert,et al.  Fecal metabolomics: assay performance and association with colorectal cancer. , 2014, Carcinogenesis.

[11]  Douglas N Rutledge,et al.  PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. , 2015, Molecular bioSystems.

[12]  M. Fischbach,et al.  A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice , 2013, The ISME Journal.

[13]  A. Carta,et al.  Determination of phenol and o-cresol by GC/MS in a fatal poisoning case. , 2004, Forensic science international.

[14]  G. Macfarlane,et al.  The control and consequences of bacterial fermentation in the human colon. , 1991, The Journal of applied bacteriology.

[15]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[16]  T. Ebbels,et al.  Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies. , 2012, Analytical chemistry.

[17]  Zerihun T. Dame,et al.  The Human Urine Metabolome , 2013, PloS one.

[18]  Christoph H Borchers,et al.  Effect of Antibiotic Treatment on the Intestinal Metabolome , 2011, Antimicrobial Agents and Chemotherapy.

[19]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[20]  R. Cela-Torrijos,et al.  Gas‐chromatographic headspace analysis of phenol and cresols in soils by direct acetylation , 1996 .

[21]  S. Kochhar,et al.  Metabolomic Applications to Decipher Gut Microbial Metabolic Influence in Health and Disease , 2012, Front. Physio..

[22]  U. Günther,et al.  Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals , 2014, Metabolomics.

[23]  C. Lee,et al.  Microbial community and metabolomic comparison of irritable bowel syndrome faeces , 2011, Journal of medical microbiology.

[24]  J. Nicholson,et al.  Dietary modulation of gut functional ecology studied by fecal metabonomics. , 2010, Journal of proteome research.

[25]  L. Ferguson,et al.  Using metabolomic analysis to understand inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[26]  Ara W. Darzi,et al.  Metabolic phenotyping in clinical and surgical environments , 2012, Nature.

[27]  T. Langmann,et al.  Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. , 2006, Biochimica et biophysica acta.

[28]  R. A. van den Berg,et al.  Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.

[29]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[30]  Hideyuki Suzuki,et al.  Polyamines : a universal molecular nexus for growth, survival, and specialized metabolism , 2015 .

[31]  Amy M. Sheflin,et al.  Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.

[32]  E. Pujos-Guillot,et al.  Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. , 2010, Analytical chemistry.

[33]  Lanjuan Li,et al.  Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[34]  T. Huan,et al.  Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. , 2015, Analytical chemistry.

[35]  W. Moon,et al.  An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy , 2011, PloS one.

[36]  A. Tjønneland,et al.  Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis , 2014, Inflammatory bowel diseases.

[37]  G. Fahey,et al.  Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. , 2014, Journal of proteome research.